Respiratory Physiology

The morphologic development of the lung begins at several weeks after conception and continues into the first decade of postnatal life.¹ Intrauterine gas exchange occurs via the placenta, but the respiratory system develops in preparation for extrauterine life, when gas exchange transfers abruptly to the lungs at birth.

Development of the lung, which begins as an outgrowth of the foregut ventral wall, can be divided into several stages (Fig. 11-1). During the embryonic period, the first few postconceptional weeks, lung buds form as a projection of the endodermal tissue into the mesenchyme. The pseudoglandular period extends to the 17th week of life, during which rapid lung growth is accompanied by formation of the bronchi and branching of the airways down to the terminal bronchioli. Further development of bronchioli and vascularization of the airways occurs during the canalicular stage of the second trimester. The saccular stage begins at approximately 24 weeks, when terminal air sacs begin to form. The capillary networks surrounding these air spaces proliferate, allowing sufficient pulmonary gas exchange for extrauterine survival of the premature neonate by 26 to 28 weeks. Formation of alveoli occurs by lengthening of the saccules and thinning of the saccular walls and has begun by the 36th postconceptional week in most human fetuses. The vast majority of alveolar formation occurs after birth, typically continuing until 8 to 10 years postnatally. The neonatal lung at birth usually contains 10 to 20 million terminal air sacs (many of which are saccules rather than alveoli), one-tenth the number in the mature adult lung. Growth of the lungs after birth occurs primarily as an increase in the number of respiratory bronchioles and alveoli rather than an increase in the size of the alveoli.

FIGURE 11-1 Timetable for lung development.

(Modified with permission from Guttentag S, Ballard PL. Lung development: embryology, growth, maturation, and developmental biology. In: Tausch HW, Ballard RA, Gleason CA, editors. Avery’s diseases of the newborn. 8th ed. Philadelphia: WB Saunders; 2004, p. 602.)

The abrupt transition to extrauterine gas exchange at birth involves the rapid expansion of the lungs, increased pulmonary blood flow, and initiation of a regular respiratory rhythm. The development of a respiratory rhythm, detectable initially by intermittent rhythmic fetal thoracic movements, begins well before birth and may be necessary for normal anatomic and physiologic lung development. Interruption of umbilical blood flow at birth initiates continuous rhythmic breathing. Amniotic fluid is expelled from the lungs via the upper airways with the first few breaths, with residual fluid draining through the lymphatic and pulmonary channels in the first days of life. Changes in the partial pressures of oxygen (Po₂) and carbon dioxide (Pco₂) and in hydrogen ion concentration (pH) cause an acute decrease in pulmonary vascular resistance and a consequent increase in pulmonary blood flow. Increased left atrial and decreased right atrial pressure reverse the pressure gradient across the foramen ovale, causing functional closure of this left-to-right one-way flap valve. Ventilatory rhythm is augmented and maintained in part by the increased arterial oxygen relative to the prior intrauterine levels.

Breathing is controlled by a complex interaction involving input from sensors, integration by a central control system, and output to effector muscles.² Afferent signaling is provided by peripheral arterial and central brainstem chemoreceptors, upper airway and intrapulmonary receptors, and chest wall and muscle mechanoreceptors.

The peripheral arterial chemoreceptors consist of the carotid and aortic bodies, with the carotid bodies playing the greater role in arterial chemical sensing of both arterial O₂ tension (Pao₂) and pH. The central chemoreceptors, responsive to arterial CO₂ tension (Paco₂) and pH, are thought to be located at or near the ventral surface of the medulla.

The nose, pharynx, and larynx have a wide variety of pressure, chemical, temperature, and flow receptors that can cause apnea, coughing, or changes in ventilatory pattern. Pulmonary receptors lie in the airways and lung parenchyma. The airway receptors are subdivided into the slowly adapting receptors, also called pulmonary stretch receptors, and the rapidly adapting receptors. The stretch receptors, found in the airway smooth muscle, are thought to be involved in the balance of inspiration and expiration. These receptors may be the sensors in the Hering-Breuer reflexes, which prevent overdistention or collapse of the lung. The rapidly adapting receptors lie between the airway epithelial cells and are triggered by noxious stimuli such as smoke, dust, and histamine. Parenchymal receptors, also known as juxtacapillary receptors, are located adjacent to the alveolar blood vessels; they respond to hyperinflation of the lungs, to various chemical stimuli in the pulmonary circulation, and possibly to interstitial congestion. Chest wall receptors include mechanoreceptors and joint proprioreceptors. Mechanoreceptors in the muscle spindle endings and tendons of respiratory muscles sense changes in length, tension, and movement.

Central integration of respiration is maintained by the brainstem (involuntary) and by cortical (voluntary) centers. Although the precise mechanism of the neural ventilatory rhythmogenesis is unknown, the pre-Bötzinger complex and the retrotrapezoid nucleus/parafacial respiratory group, neural circuits in the ventrolateral medulla, are thought to be the respiratory rhythm generators.³ These neuron groups fire in an oscillating pattern, an inherent rhythm that is moderated by inputs from other respiratory centers. Involuntary integration of sensory input occurs in various respiratory nuclei and neural complexes in the pons and medulla that modify the baseline pacemaker firing of the respiratory rhythm generators. The cerebral cortex also affects breathing rhythm and influences or overrides involuntary rhythm generation in response to conscious or subconscious activity, such as emotion, arousal, pain, speech, breath holding, and other activities.²

The effectors of ventilation include the neural efferent pathways, the muscles of respiration, the bones and cartilage of the chest wall and airway, and elastic connective tissue. Upper airway patency is maintained by connective tissue and by sustained and cyclic contractions of the pharyngeal dilator muscles. The diaphragm produces the majority of tidal volume during quiet inspiration, with the intercostal, abdominal, and accessory muscles (sternocleidomastoid and neck muscles) providing additional negative pressure. The elastic recoil of the lungs and thorax produces expiration. Inspiration is an active and expiration a passive action in normal lungs during quiet breathing. During vigorous breathing or with airway obstruction, both inspiration and expiration become active processes.

Another effect of age is a change in chest wall compliance. In adults, the end-expiratory volume is equivalent to the functional residual capacity (FRC). In infants, the chest wall is more compliant, so the tendency of the lung to collapse is not adequately counterbalanced by chest wall rigidity. Infants stop expiration at a lung volume greater than FRC, with the inspiratory muscles braking expiration. When this braking mechanism is impaired, as occurs with general anesthesia, the infant has a tendency to develop atelectasis.

Preoperative Assessment

The preoperative assessment of the respiratory system in a child is based on the history, physical examination, and evaluation of vital signs. Because ventilation is a complex process involving many systems besides the lung, the pulmonary appraisal must also include an assessment of airway, musculoskeletal, and neurologic pathology that might affect gas exchange under anesthesia or in the postoperative period. The potential impacts of esophageal reflux and cardiac, hepatic, renal, or hematologic disease on gas exchange and pulmonary function should be considered. Further investigations, such as laboratory, radiographic, and pulmonary function studies, may be indicated if there is doubt as to the diagnosis or severity of the pulmonary disease.

Because children may be unwilling or unable to give a reliable history, parents or caregivers are often the sole source or an important supplemental source of information during initial evaluation. Risk factors in the history that are associated with an increased risk of perioperative events include a respiratory tract infection within the preceding 2 weeks, wheezing during exercise, more than three wheezing episodes in the past 12 months, nocturnal dry cough, eczema, and a family history of asthma, rhinitis, eczema, or exposure to tobacco smoke.^1,4 Viral upper respiratory tract infections (URIs) are common in children, and the time, frequency, and severity of infection should be established. If wheezing is present, the precipitating causes, frequency, severity, and relieving factors should be determined. Chronic pulmonary diseases often have a variable clinical course, and the details of acute exacerbations of chronic problems should be elicited.

In younger children, the gestational age at birth, the current postmenstrual age, neonatal respiratory difficulties, and prolonged intubation in the neonatal period are particularly important to ascertain. Apneic episodes, subglottic stenosis, and tracheomalacia are possible complications of prematurity and prolonged intubation that may be exacerbated in the perioperative period. Whereas congenital lesions often manifest at birth, symptoms of airway collapse or stenosis may become evident only later in life.

Physical examination begins when you enter the room. Particularly with young children, your best opportunity to observe them before they react to your presence is from across the room, and inspection from a distance can provide useful information. Respiratory rate is a sensitive marker of pulmonary problems, and scrutiny of the rate before a young child becomes agitated and hyperventilates is an important metric. Pulse oximetry is a useful baseline indicator of oxygenation. Nasal flaring, intercostal retractions, and the marked use of accessory respiratory muscles are all signs of respiratory distress. General appearance is also important. Apathy, anxiety, agitation, or persistent adoption of a fixed posture may indicate profound respiratory or airway difficulties, and intense cyanosis can also be detected from a distance. Weight may relate to pulmonary function: Children with chronic severe pulmonary disease are often underweight owing to retarded growth or malnourishment, whereas severe obesity can produce airway obstruction and sleep apnea. Inspection of the chest contour may reveal hyperinflation or thoracic wall deformities.

Closer physical examination adds further information. Atopy and eczema may be associated with hyperreactive airways. Auscultation may reveal wheezes, rales, fine or coarse crepitus, transmitted breath sounds from the upper airway, altered breath sounds, or cardiac murmurs. Chest percussion can provide an estimate of the position of the diaphragm and serve as a useful marker of hyperinflation. Patience, a gentle approach, and warm hands improve diagnostic yield and patient satisfaction.

Pulmonary Function Tests

Further pulmonary investigations include chest imaging, measurement of hematocrit, arterial blood gas analysis, pulmonary function tests, and sleep studies. Special investigations are not routinely indicated preoperatively and should be reserved for cases in which the diagnosis is unclear, the progression or treatment of a disease needs to be established, or the severity of impairment is not evident. In most cases, a comprehensive history and careful physical examination are adequate to establish an appropriate anesthetic plan. Before requesting a new investigation, the clinician should have a clear idea of the question the test is expected to answer and how the answer will modify anesthetic management and outcome. Many tests are difficult to perform in children who have short attention spans and who cannot sit still for any length of time. Judgment must be exercised when ordering these tests for young children, and due consideration must be given to the child’s age and level of maturity and the influence of the parents.

Pulmonary function tests include dynamic studies, measurement of static lung volumes, and diffusing capacity. Pulmonary function tests enable clinicians to (1) establish mechanical dysfunction in children with respiratory symptoms, (2) quantify the degree of dysfunction, and (3) define the nature of the dysfunction as obstructive, restrictive, or mixed obstructive and restrictive.⁵ Table 11-1 presents common indications for pulmonary function testing in children.

TABLE 11-1 Uses of Pulmonary Function Studies in Children

The dynamic studies, which are the most commonly used tests, include spirometry, flow–volume loops, and measurement of peak expiratory flow. Spirometry measures the volume of air inspired and expired as a function of time and is by far the most frequently performed test of pulmonary function in children. With a forced exhalation after a maximal inhalation, the total volume exhaled is known as the forced vital capacity (FVC), and the fractional volume exhaled in the first second is known as the forced expiratory volume in 1 second (FEV₁). Figure 11-2 illustrates a normal pulmonary function test (normal flow–volume loop and spirometry parameters).

FIGURE 11-2 Normal pulmonary function test. The normal flow–volume curve obtained during forced expiration rapidly ascends to the peak expiratory flow (highest point on curve), then descends with decreasing volume, following a reproducible shape that is independent of effort. In this normal flow–volume curve, the forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and FEV₁/FVC ratio are all within the normal range for this child’s age, height, gender, and race. The shapes of both the inspiratory and expiratory limbs are normal as well. Pre, Prebronchodilator; Pred, predicted value.

An obstructive process is characterized by decreased velocity of airflow through the airways (Fig. 11-3), whereas a restrictive defect produces decreased lung volumes (Fig. 11-4). Examination of the ratio of airflow to lung volume assists in differentiating these components of lung disease. Normally, a child should be able to exhale more than 80% of the FVC in the first second. Children with obstructive lung disease have decreased airflow in relation to exhaled volume. If the volume exhaled in the first second divided by the volume of full exhalation (FEV₁/FVC) is less than 80%, then airway obstruction is present (Table 11-2; see Fig. 11-3).

FIGURE 11-3 This flow–volume curve demonstrates a reversible obstructive defect. The forced expiratory volume in 1 second (FEV₁) as a percentage of forced vital capacity (FVC), or total volume exhaled, is decreased in patients with airway obstruction. The observed curve shape before bronchodilator use (blue curve) is scooped. After administration of a short-acting bronchodilator, the observed curve shape (brown) appears normal, and there is an increase in both FEV₁/FVC and FEV₁. This child has asthma and demonstrates a marked (40%) increase in FEV₁ after treatment with a short-acting bronchodilator. Reversible airflow obstruction is one of the hallmarks of asthma. Post, Postbronchodilator; Pre, prebronchodilator; Pred, predicted value.

FIGURE 11-4 Flow–volume curve demonstrating a restrictive defect. The flow–volume curves in children with restrictive defects are near-normal in configuration but smaller in all dimensions. The ratio of forced expiratory volume in 1 second (FEV₁) to forced vital capacity (FVC) is normal, but both FEV₁ and FVC are reduced. The curve shape appears normal. This child has interstitial lung disease. Pred, Predicted value.

TABLE 11-2 Characteristics of Obstructive and Restrictive Patterns of Lung Disease

The FEV₁ needs to be interpreted in the context of the FVC. A small FEV₁ alone is insufficient evidence on which to make a diagnosis of airflow obstruction. Those with restrictive lung disease have both decreased FEV₁ and FVC—decreased flow rate and reduced total exhaled volume. Restrictive lung disease is associated with a loss of lung tissue or a decrease in the lung’s ability to expand. A restrictive defect is diagnosed when the FVC is less than 80% of normal with either a normal or an increased FEV₁/FVC (see Table 11-2 and Fig. 11-4).

Most children with respiratory problems have an obstructive pattern; isolated restrictive diseases are far less common. Asthma is the most common obstructive pulmonary disease in children. Rare causes of obstruction include airway lesions, congenital subglottic webs, and vocal cord dysfunction. Restrictive lung disease can arise from limitations to chest wall movement such as chest wall deformities, scoliosis, or pleural effusions or from space-occupying intrathoracic pathology such as large bullae or congenital cysts. Alveolar filling defects (e.g., lobar pneumonia) also reduce lung volume and can be considered as restrictive processes. Although the diseases arise from specific isolated genetic disorders, children with cystic fibrosis (CF) and sickle cell disease (SCD) can have highly variable pulmonary pathologic processes with both obstructive and restrictive components of lung disease. Bronchopulmonary dysplasia may also result in both obstructive and restrictive pathology.

Pulmonary function tests can also be used to differentiate fixed from variable airway obstruction and to localize the obstruction as above or below the thoracic inlet (Figs. 11-5 through 11-7, E-Fig. 11-1). This information can be gleaned from distinctive changes in the configuration of the flow–volume loop, a graphic representation of inspiratory and expiratory flow volumes plotted against time. A fixed central airway obstruction, such as a tumor or stenosis, may obstruct both inspiration and expiration, flattening the flow–volume curve on both inspiration and expiration (See Video 12-1). The child with tracheal stenosis, for example, has flattening of both inhalation and exhalation curves (see Fig. 11-6). A variable obstruction tends to affect only one part of the ventilatory cycle. On inhalation, the chest expands and draws the airways open. On exhalation, as the chest collapses, the intrathoracic airways collapse. Variable extrathoracic lesions tend to obstruct on inhalation more than exhalation, whereas variable intrathoracic lesions tend to obstruct more on exhalation. This produces the characteristic flow–volume patterns.

FIGURE 11-5 Pulmonary function test demonstrating a nonreversible obstructive defect. The ratio of forced expiratory volume in 1 second (FEV₁) to forced vital capacity (FVC) is decreased, as is the FEV₁. After administration of a short-acting bronchodilator, there is no significant improvement in the FEV₁, in contrast to the pattern in Figure 11-3. This child has cystic fibrosis with a nonreversible obstructive defect. Post, Postbronchodilator; Pre, prebronchodilator; Pred, predicted value.

FIGURE 11-6 Pulmonary function test showing an extrathoracic airway obstruction; both the inspiratory and expiratory limbs of the flow–volume curve are flattened. This child has subglottic stenosis that developed at the site of her tracheotomy 2 years after the tracheostomy was removed. FEV₁, Forced expiratory volume in 1 second; FVC, forced vital capacity; Pred, predicted value.

FIGURE 11-7 A, Pulmonary function test from a child with an intrathoracic airway obstruction (vascular ring). The flow–volume curves suggest a fixed expiratory obstruction. The shape of the inspiratory link is normal; the expiratory flow limb is flattened on both the prebronchodilator (brown) and postbronchodilator (blue) flow–volume curves. B, Slit-like tracheal compression before repair. C, Marked improvement in the tracheal lumen after division of the vascular ring. (See E-Fig. 11-1 for a magnetic resonance imaging angiogram of a vascular ring.)

(Photographs B and C courtesy Christopher Hartnick, MD.) FEV₁, Forced expiratory volume in 1 second; FVC, forced vital capacity; Pred, predicted value.

E-Figure 11-1 A magnetic resonance angiogram accompanies the flow loop in Figure 11-7, demonstrating anomalous aortic anatomy compressing the trachea.

(Courtesy Brian O’Sullivan, MD.)

In addition to diagnostic uses, spirometry is used to assess the indication for, and efficacy of, treatment. For example, the obstruction in patients with asthma is usually reversible, either gradually over time without intervention or much more rapidly after treatment with a short-acting bronchodilator. An improvement in FEV₁ of 12% and 200 mL is considered a positive response. In addition to confirming the diagnosis of asthma, the degree of airflow obstruction, as indicated by the FEV₁, is one measure of asthma control. A low FEV₁ or an acute decrease from baseline may indicate a child whose asthma is not under good control and therefore who potentially is at greater risk for a perioperative exacerbation (see Fig. 11-3).

Because it measures the amount of air entering or leaving the lung rather than the amount of air in the lung, spirometry cannot provide data about absolute lung volumes. Information about FRC and lung volumes calculated from FRC, such as total lung capacity and residual volume, must be obtained by different means, such as gas dilution or body plethysmography. Gas dilution is based on measuring the dilution of nitrogen or helium in a circuit in closed connection to the lungs, whereas body plethysmography calculates lung gas volumes based on changes in thoracic pressures.

Perioperative Etiology and Epidemiology

Respiratory problems account for most of the perioperative morbidity in children,^6,7 and cause almost one third of perioperative pediatric cardiac arrests.⁸ Adverse events include laryngospasm, airway obstruction, bronchospasm, hemoglobin oxygen desaturation, prolonged coughing, atelectasis, pneumonia, and respiratory failure.^4,9,10 The incidence of perioperative adverse respiratory events in one study of 755 children was 34%,⁹ whereas in another observational study of 9297 children it was 15%.⁴ The triggers of these problems included airway manipulation, alteration of airway reflexes by anesthetic drugs, surgical insult, and depression of breathing caused by anesthetic and analgesic medications. Various diseases common among children can further affect the frequency of respiratory complications in pediatric anesthesia.

Studies have consistently reported greater respiratory morbidity among younger compared with older children.^{4,6,7,11–13} In particular, neonates are sensitive to respiratory problems for many reasons. Although the FRC approaches adult capacity (in liters per kilogram) within days after birth, a persistently large closing capacity increases the likelihood of alveolar collapse and intrapulmonary shunt. Residual patency of the ductus arteriosus can contribute to shunting. The greater metabolic rate of the infant increases oxygen requirements and decreases the time to arterial desaturation after an interruption to ventilation and gas exchange. The work of breathing is greater due to high-resistance, small-caliber airways, increased chest wall compliance, and reduced lung parenchymal compliance.

Upper Respiratory Tract Infection

Upper repiratory tract infections (URIs) are a common problem among young children. Children are typically infected several times a year, possibly even more frequently if they are in day care. Viruses cause the majority of URIs, with rhinoviruses constituting approximately one third to one half of etiologic species.^14,14a Other common respiratory viruses in childhood include adenoviruses and coronaviruses.

Although most URIs are short-lived, self-limited infections and are by definition limited to the upper airway, they may increase airway sensitivity to noxious stimuli or secretions for several weeks after the infection has cleared. The mechanisms probably involve a combination of mucosal invasion, chemical mediators, and altered neurogenic reflexes.¹⁴ URIs may also impair pulmonary function by decreasing FVC, FEV₁, peak expiratory flow, and diffusion capacity.^15,16

Compared with uninfected children, children with a recent or current URI have an increased incidence of perioperative laryngospasm, bronchospasm, arterial hemoglobin desaturation, severe coughing, and breath holding (Table 11-3).^{4,12,13,17–20} However, most complications can usually be predicted and successfully managed without long-term sequelae by suitably experienced and prepared clinicians.^{14,18,20–23} An approach to the child with a URI is to detect the pathologic process and associated comorbidity, establish the acuteness and severity of the URI, and then decide whether to modify the anesthetic technique or postpone surgery (Table 11-4, Fig. 11-8).

TABLE 11-3 Incidence of Common Upper Respiratory Tract Infection–Associated Perioperative Adverse Events

TABLE 11-4 Risk Factors for Perioperative Adverse Events in Children with Upper Respiratory Tract Infections

FIGURE 11-8 Suggested algorithm for assessment and management of the child with an upper respiratory tract infection (URI). ETT, Endotracheal tube; Hx, history; LMA, laryngeal mask airway.

(Modified from Tait AR, Malviya S. Anesthesia for the child with an upper respiratory tract infection: still a dilemma? Anesth Analg 2005;100:59-65.)

The basis for diagnosing a URI is a careful history and physical examination, with further investigations in limited situations. Because they are usually familiar with their child’s state of health, the parents or caregivers can provide helpful insight into the presence and severity of a URI. The child should be evaluated for fever (defined as a temperature greater than 100.4° F [38° C]), change in demeanor or behavior, dyspnea, productive cough, purulent sputum production, nasal congestion, rales, rhonchi, and wheezing. A chest radiograph may be considered if the pulmonary examination is questionable, but because the radiographic changes lag behind clinical symptoms, it is typically of limited value. Although laboratory tests may confirm the diagnosis of a viral or bacterial URI, they are not cost-effective or practical in a busy surgical setting.

For children with symptoms of an uncomplicated URI who are afebrile with clear secretions and who are otherwise healthy, anesthesia may proceed as planned, because the problems encountered are typically transient and easily managed.^{4,14,18,20–23} Elective surgery is usually postponed for children with more severe symptoms that include at least one of the following: mucopurulent secretions; lower respiratory tract signs (e.g., wheezing) that do not clear with a deep cough; a pyrexia greater than 100.4° F (38° C); or a change in sensorium (e.g., not behaving or playing normally, has not been eating properly).^14,23

The decision to proceed with surgery becomes much more difficult when the signs of the URI are between the extremes of mild and severe. For these intermediate URIs, other considerations play a greater role in assessment of the risk/benefit ratio. These include the presence of comorbidities such as asthma, cardiac disease, or obstructive sleep apnea; a history of prematurity; the frequency of URIs; prior cancellations; the type, complexity, duration, and urgency of the surgery; the age of the child; and the socioeconomic implications for the family. The comfort level and experience of the anesthesiologist may also be an underestimated but important factor in the decision to proceed with or postpone surgery, because less experienced anesthesiologists have a greater incidence of complications.⁴ The need to admit a child postoperatively because of anesthetic complications or an exacerbation of the URI may expose other children to a contagious illness.

If the decision is to proceed with general anesthesia, management is directed toward avoiding stimulation of the potentially sensitized airway. Use of an endotracheal tube (ETT) should be avoided, if possible, because it increases the risk of complications, especially in younger children.^4,18 Although airway management with a facemask is associated with the smallest frequency of airway complications,⁴ it may be inappropriate for certain cases. The laryngeal mask airway (LMA) is associated with fewer episodes of respiratory events than an ETT, but its use may similarly be contraindicated by the type of surgical procedure and the need to protect the airway from pulmonary aspiration of gastric contents.

Whichever airway technique is chosen, it is essential that the depth of anesthesia be adequate to obtund airway reflexes during placement of an airway device. The optimal depth of anesthesia at which to remove an airway device is less clearly defined. Several studies in children with and without URI did not detect a difference in emergence complications between awake and deep extubation,^4,13,18,24 whereas others found a greater incidence of arterial oxygen desaturation or coughing after removal of the ETT or LMA in awake children.^25,26

The optimal time when an anesthetic can be given after a URI without increasing the risk of adverse respiratory events remains contentious, but most clinicians wait 2 to 4 weeks after the resolution of the URI before proceeding.^4,13,27 This reflects a balance among three critical factors: the time interval to diminish both upper and lower airway hyperreactivity; the perioperative respiratory risk, which includes a recurrence of the URI; and the need to perform the procedure.

Anesthetic techniques may affect complication rates. An observational study of 9297 children reported significantly less laryngospasm after maintenance of anesthesia with propofol than with sevoflurane.⁴ This finding might be attributed to a differential effect of propofol versus sevoflurane on airway reflexes.²⁸ The effect of spraying the cords with lidocaine on the incidence of laryngospasm and bronchospasm is unclear.⁴ However, a randomized, controlled trial showed that topical lidocaine gel lubricant applied to the LMA in children with URIs significantly reduced the frequency of adverse airway events.²⁹ Prophylactic treatment with glycopyrrolate, ipratropium, or albuterol is not effective in preventing URI-related adverse events.^30,31 However, an observational study reported that prophylactic salbutamol was effective in reducing perioperative airway sequelae in children with URIs.³² Nasal vasoconstrictors (such as phenylephrine or oxymetazoline nose drops) have been recommended for reducing oropharyngeal secretions in children with URIs, but their efficacy remains anecdotal.²³

Lower Airway Disease

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

Perioperative Behavioral Stress in Children Total Intravenous Anesthesia and Target-Controlled Infusion Medicolegal Issues Organ Transplantation Neonatal Emergencies Ultrasound-Guided Regional Anesthesia

Stay updated, free articles. Join our Telegram channel

Join